Literature DB >> 4309908

Properties of the xanthine oxidase from human liver.

E Della Corte, G Gozzetti, F Novello, F Stirpe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4309908     DOI: 10.1016/0005-2744(69)90327-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  16 in total

Review 1.  Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases.

Authors:  Luisa B Maia; José J G Moura
Journal:  J Biol Inorg Chem       Date:  2015-01-15       Impact factor: 3.358

Review 2.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

3.  Milk xanthine oxidase type D (dehydrogenase) and type O (oxidase). Purification, interconversion and some properties.

Authors:  M G Battelli; E Lorenzoni; F Stripe
Journal:  Biochem J       Date:  1973-02       Impact factor: 3.857

Review 4.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

5.  The regulation of xanthine oxidase. Inhibition by reduced nicotinamide-adenine dinucleotide of rat liver xanthine oxidase type D and of chick liver xanthine dehydrogenase.

Authors:  E Della Corte; F Stirpe
Journal:  Biochem J       Date:  1970-03       Impact factor: 3.857

6.  The role of molybdenum in human biology.

Authors:  M P Coughlan
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

7.  Xanthine dehydrogenase AtXDH1 from Arabidopsis thaliana is a potent producer of superoxide anions via its NADH oxidase activity.

Authors:  Maryam Zarepour; Katrin Kaspari; Stefan Stagge; Ralf Rethmeier; Ralf R Mendel; Florian Bittner
Journal:  Plant Mol Biol       Date:  2009-11-14       Impact factor: 4.076

Review 8.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Authors:  Cristine E Berry; Joshua M Hare
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

9.  Xanthine Oxidoreductase Inhibitors.

Authors:  Keeran Vickneson; Jacob George
Journal:  Handb Exp Pharmacol       Date:  2021

Review 10.  Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury.

Authors:  José Lillo-Moya; Catalina Rojas-Solé; Diego Muñoz-Salamanca; Emiliano Panieri; Luciano Saso; Ramón Rodrigo
Journal:  Antioxidants (Basel)       Date:  2021-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.